SCHEMBL31361145

SCHEMBL31361145

Cc1cc(C#N)n(-c2nc(Cl)ccc2C(F)(F)F)n1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 7/20 0.40
KDM4E B2RXH2 3/20 0.38
HTT P42858 2/20 0.34
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34
MAPK1 P28482 1/20 0.34
NTSR1 P30989 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
HSP90AA1 P07900 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
NOTUM Q6P988 1/20 0.33
POLQ O75417 1/20 0.32
AR P10275 1/20 0.32
LRRK2 Q5S007 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31361289 0.80 GRM2 (0.40) GRM2KDM4EHTTLMNATP53
SCHEMBL31361174 0.77 KDM4E (0.33) GRM2KDM4EHTTKMT2A
SCHEMBL25318266 0.76 MEN1 (0.39) KDM4EHTTMAPK1KMT2ASMN1; SMN2
SCHEMBL31153160 0.76 MEN1 (0.39) KDM4EHTTMAPK1KMT2ASMN1; SMN2
SCHEMBL31361222 0.75 KDM4E (0.36) KDM4EHTTLMNASMN1; SMN2
SCHEMBL31361215 0.74 KDM4E (0.33) KDM4EHTTLMNASMN1; SMN2
SCHEMBL31361117 0.73 KDM4E (0.38) KDM4ELMNASMN1; SMN2
SCHEMBL31361244 0.71 GRM2 (0.34) GRM2KDM4ENOTUMAR
SCHEMBL3290485 0.67 POLB (0.55) KDM4EHTTLMNAMAPK1KMT2A
SCHEMBL2708931 0.66 MBOAT4 (0.38) GRM2KDM4EHTTLMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4746965-A1 BENZIMIDAZOLES AS SIK-ACTIVITY MODULATORS F. Hoffmann-La Roche AG (CH) 2026-05-27 EP disclosed
WO-2025017041-A1 BENZIMIDAZOLES AS SIK-ACTIVITY MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2025-01-23 WO disclosed